differences between closeas and omega 3 Plus and their uses

differences between closeas and omega 3 Plus and their uses include strengthening memory, increasing energy, and supporting overall hair, body, and skin health. They are also effective in improving and strengthening bone health, reducing joint pain, supporting eye health, and enhancing vision. This is due to their active ingredients that support various bodily functions and help lower triglyceride and cholesterol levels in the blood. We will learn about the differences between them, how to use them, and all relevant information in the rest of the article.

Closeas Ingredients

It consists of cod liver oil, extracted from the liver of Atlantic cod. It is characterized by its omega-3 fatty acids, which have numerous health benefits, such as lowering cholesterol and harmful fats, reducing inflammation, and lowering high blood pressure.

Omega 3 Plus Ingredients

It consists of the following active ingredients:

• Wheat germ oil, which is rich in vitamin E and has antioxidant effects.
• Fish oil is a natural source of fatty acids that help lower triglyceride and cholesterol levels in the blood.

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 19 August 2025